<i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and ParagangliomaNelly Burnichon, Elisa Taschin, Salud Borrego et al.|Clinical Cancer Research|2012Cited by 330
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or PheochromocytomaAlexandre Buffet, Laurène Ben Aim, Sophie Leboulleux et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 124
Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluationKarine Renaudin, D. Drui, Sarra Smati et al.|Modern Pathology|2018Cited by 43
Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First AppraisalSophie Moog, Éric Baudin, Frédéric Castinetti et al.|The Journal of Clinical Endocrinology & Metabolism|2021Cited by 16
Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytomaAlexandre Buffet, Anne‐Paule Gimenez‐Roqueplo, Laurène Ben Aim et al.|Endocrine Abstracts|2019Cited by 1